Novo Holdings A/S 13F 持仓 · 2026年Q2
Novo Holdings A/S 在 2026年Q2（报告期截至 2026-06-30）的 SEC 13F 申报中报告了 25 只证券，申报市值合计 17.22 亿美元。前几大持仓：EWTX（12.62%）、ASML（10.97%）、COAG（8.92%）。本季前 25 大持仓中：新建仓 6 只、增持 2 只、减持 8 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | EWTX | EDGEWISE THERAPEUTICS INC | $217.4M | 12.62% | 5.3M | 持平 |
| 2 | ASML | ASML HOLDING N V | $188.9M | 10.97% | 94,946 | 持平 |
| 3 | COAG | HEMAB THERAPEUTICS HLDGS INC | $153.6M | 8.92% | 4.2M | 新建仓 |
| 4 | BN | BROOKFIELD CORP | $149.5M | 8.68% | 3.5M | 持平 |
| 5 | MPLT | MAPLIGHT THERAPEUTICS INC | $132.1M | 7.67% | 3.7M | 持平 |
| 6 | MIRM | MIRUM PHARMACEUTICALS INC | $131.7M | 7.65% | 1.1M | 减持 |
| 7 | AVLN | AVALYN PHARMACEUTICALS INC | $127.8M | 7.42% | 3.9M | 新建仓 |
| 8 | CRM | SALESFORCE INC | $61.6M | 3.58% | 393,187 | 持平 |
| 9 | AVBP | ARRIVENT BIOPHARMA INC | $52.1M | 3.03% | 1.5M | 减持 |
| 10 | ELVN | ENLIVEN THERAPEUTICS INC | $50.8M | 2.95% | 1.0M | 减持 |
| 11 | CRNX | CRINETICS PHARMACEUTICALS IN | $49.4M | 2.87% | 1.3M | 减持 |
| 12 | PHVS | PHARVARIS N V | $48.4M | 2.81% | 1.4M | 减持 |
| 13 | FND | FLOOR & DECOR HLDGS INC | $47.3M | 2.75% | 797,000 | 新建仓 |
| 14 | PCVX | VAXCYTE INC | $46.5M | 2.70% | 800,000 | 减持 |
| 15 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $43.2M | 2.51% | 3.2M | 减持 |
| 16 | VRDN | VIRIDIAN THERAPEUTICS INC | $39.2M | 2.28% | 2.1M | 增持 |
| 17 | CLDX | CELLDEX THERAPEUTICS INC NEW | $38.1M | 2.21% | 1.0M | 减持 |
| 18 | ALMS | ALUMIS INC | $31.0M | 1.80% | 1.1M | 新建仓 |
| 19 | XENE | XENON PHARMACEUTICALS INC | $29.3M | 1.70% | 485,438 | 持平 |
| 20 | BABA | ALIBABA GROUP HLDG LTD | $24.7M | 1.43% | 257,327 | 持平 |
| 21 | DYN | DYNE THERAPEUTICS INC | $21.3M | 1.24% | 960,394 | 新建仓 |
| 22 | BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | $17.1M | 1.00% | 2.2M | 增持 |
| 23 | INSM | INSMED INC | $12.9M | 0.75% | 120,723 | 新建仓 |
| 24 | MQ | MARQETA INC | $7.2M | 0.42% | 441,558 | 持平 |
| 25 | LNZA | LANZATECH GLOBAL INC | $1.1M | 0.06% | 158,148 | 持平 |
来源：SEC 13F 申报文件 · 截至 2026-06-30
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR